109 related articles for article (PubMed ID: 3000142)
1. Responses of plasma cyclic AMP, serum immunoreactive insulin, C-peptide immunoreactivity and blood sugar levels to glucagon in patients with liver diseases.
Shimamura J; Taketa K; Ide T; Nakata K; Nagashima H
Acta Med Okayama; 1985 Oct; 39(5):385-96. PubMed ID: 3000142
[TBL] [Abstract][Full Text] [Related]
2. Changes in immunoreactive insulin, C-peptide immunoreactivity, and immunoreactive glucagon in acute viral hepatitis.
Kaneko K; Arai M; Funatomi H; Hatta Y; Mitamura K
J Gastroenterol; 1995 Oct; 30(5):624-31. PubMed ID: 8574335
[TBL] [Abstract][Full Text] [Related]
3. Analysis of insulin secretion based on changes in plasma insulin and C-peptide in man.
Sakai T; Ohneda A; Nihei J; Kobayashi T
Tohoku J Exp Med; 1982 Dec; 138(4):427-40. PubMed ID: 6761899
[TBL] [Abstract][Full Text] [Related]
4. Degradation and secretion of insulin in hepatic cirrhosis.
Iwasaki Y; Ohkubo A; Kajinuma H; Akanuma Y; Kosaka K
J Clin Endocrinol Metab; 1978 Oct; 47(4):774-9. PubMed ID: 400732
[TBL] [Abstract][Full Text] [Related]
5. [Pancreatic polypeptide response to oral glucose load in patients with liver cirrhosis--interrelationship between PP and other pancreatic endocrine hormones].
Kawakami K
Nihon Naibunpi Gakkai Zasshi; 1988 Mar; 64(3):155-70. PubMed ID: 3294051
[TBL] [Abstract][Full Text] [Related]
6. Plasma levels of insulin, C-peptide and glucagon in liver cirrhosis.
Gragnoli G; Signorini AM; Tanganelli I
J Endocrinol Invest; 1981; 4(1):1-5. PubMed ID: 7016966
[TBL] [Abstract][Full Text] [Related]
7. Glucagon-induced alterations of plasma levels of cyclic AMP and glucose in patients with liver disease.
Klotz U; Antonin KH
Z Gastroenterol; 1984 Mar; 22(3):147-52. PubMed ID: 6326401
[TBL] [Abstract][Full Text] [Related]
8. Insulin and C-peptide in ascitic fluid and plasma and their relative responses to glucagon in patients with cirrhosis.
Akgün S; Samanta A; Ertel NH
J Endocrinol Invest; 1988 Dec; 11(11):789-93. PubMed ID: 3066813
[TBL] [Abstract][Full Text] [Related]
9. Human plasma C-peptide immunoreactivity: its correlation with immunoreactive insulin in diabetes, and chronic liver and renal diseases.
Kajinuma H; Kanazawa Y; Sando H; Hayashi M; Kawazu S; Kosaka K
Endocrinol Jpn; 1979 Feb; 26(1):65-73. PubMed ID: 436802
[TBL] [Abstract][Full Text] [Related]
10. [Behavior of plasma insulin, C-peptide and glucagon in normal subjects and in patients with liver cirrhosis].
Gragnoli G; Tanganelli I; Signorini AM
Boll Soc Ital Biol Sper; 1980 Jan; 56(1):69-75. PubMed ID: 7002168
[TBL] [Abstract][Full Text] [Related]
11. Glucose, immunoreactive insulin and C-peptide immunoreactivity in patients with acute viral hepatitis.
Scremin S; Caprioglio L; D'Aquino M; Virgili F; Fabbro A; Okolicsanyi L
Horm Metab Res; 1983 Jul; 15(7):313-6. PubMed ID: 6350137
[TBL] [Abstract][Full Text] [Related]
12. [The cyclic AMP, insulin and glucose responses to glucagon stimulation in patients with liver cirrhosis according to the stage of development ].
Esteva Díaz F; Ducóns García J; Ceña Lázaro G; Márquez Galván M; Juste Rullo G; Barrao Comps F
Rev Clin Esp; 1986 Nov; 179(7):347-51. PubMed ID: 3025944
[No Abstract] [Full Text] [Related]
13. [Effects of intravenous perfusion of glucagon on plasma concentrations of glucose, insulin and cyclic AMP in patients with hepatic cirrhosis].
Conde Yagüe R; Gutiérrez-Cortines Corral MD; Ledesma Castaño F; González Coterillo T; Valle Cagigas M; González Puerta C
Rev Clin Esp; 1985 Oct; 177(5):209-11. PubMed ID: 3001846
[No Abstract] [Full Text] [Related]
14. Cyclic AMP metabolism and adenylate cyclase concentration in patients with advanced hepatic cirrhosis.
Francavilla A; Jones AF; Starzl TE
Gastroenterology; 1978 Dec; 75(6):1026-32. PubMed ID: 213345
[TBL] [Abstract][Full Text] [Related]
15. Plasma cyclic adenosine-3', 5'-monophosphate response to glucagon in patients with liver disease.
Davies TF; Prudhoe K; Douglas AP
Br Med J; 1976 Apr; 1(6015):931-3. PubMed ID: 178399
[TBL] [Abstract][Full Text] [Related]
16. Plasma glucose, insulin, proinsulin, C-peptide and glucagon before and after a carbohydrate-rich meal in hyperthyroid patients.
Rovira A; Valdivielso L; Ortega R; Valverde I; Herrera Pombo JL
Diabete Metab; 1987; 13(4):431-5. PubMed ID: 3315763
[TBL] [Abstract][Full Text] [Related]
17. Studies of glucose intolerance in cirrhosis of the liver.
Shankar TP; Solomon SS; Duckworth WC; Himmelstein S; Gray S; Jerkins T; Bobal MA; Iyer RS
J Lab Clin Med; 1983 Oct; 102(4):459-69. PubMed ID: 6352838
[TBL] [Abstract][Full Text] [Related]
18. Insulin, C-peptide and glucagon levels during OGTT in hepatic cirrhosis and in patients with prehepatic block.
Gerö L; Korányi L; Szalay F; Büki B; Tamás G
Acta Diabetol Lat; 1982; 19(1):55-64. PubMed ID: 7041501
[TBL] [Abstract][Full Text] [Related]
19. Impaired plasma cyclic AMP response to exogenous glucagon in acute liver injury.
Miyakoshi H; Noda Y; Uchida S; Tanaka N; Noto Y; Kato Y; Kawai K; Hayakawa H; Kobayashi K; Hattori N
J Clin Gastroenterol; 1984 Aug; 6(4):337-42. PubMed ID: 6090530
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of body weight, hyperinsulinemia and oral glucose load on serum C-peptide/insulin molar ratio.
Okada N; Kobayashi M; Ohtsuka H; Shigematsu S; Nagasawa Y; Komatsu M; Aizawa T; Yamada T
Horm Metab Res; 1992 Sep; 24(9):429-33. PubMed ID: 1427614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
